dengu
viru
emerg
infecti
agent
infect
estim
million
peopl
annual
worldwid
yet
current
diagnost
practic
detect
etiolog
pathogen
denguelik
ill
metagenom
approach
pathogen
detect
viral
microarray
deep
sequenc
promis
tool
address
emerg
nondiagnos
diseas
challeng
studi
use
virochip
microarray
deep
sequenc
character
spectrum
virus
present
human
sera
nicaraguan
patient
present
denguelik
symptom
test
neg
dengu
viru
util
barcod
strategi
simultan
deep
sequenc
multipl
serum
specimen
gener
averag
million
read
per
sampl
implement
stepwis
bioinformat
filter
pipelin
remov
major
human
lowqual
sequenc
improv
speed
accuraci
subsequ
unbias
databas
search
deep
sequenc
abl
detect
viru
sequenc
previous
neg
case
includ
case
human
herpesviru
sequenc
sampl
contain
sequenc
similar
sequenc
virus
herpesvirida
flavivirida
circovirida
anellovirida
asfarvirida
parvovirida
famili
case
put
viral
sequenc
virtual
ident
known
virus
other
diverg
suggest
may
deriv
novel
virus
result
demonstr
util
unbias
metagenom
approach
detect
known
diverg
virus
studi
tropic
febril
ill
viral
infect
pose
signific
global
health
burden
especi
develop
world
infecti
diseas
death
occur
children
commonli
due
prevent
treatabl
agent
effect
diagnost
surveil
tool
crucial
reduc
disabilityadjustedlifeyear
dali
due
infecti
agent
bolster
elimin
treatment
program
previous
unrecogn
novel
pathogen
continu
emerg
due
global
climat
chang
environment
encroach
pose
import
diagnost
challeng
dengu
viru
denv
infect
common
arthropodborn
viral
diseas
human
estim
million
clinic
infect
occur
annual
worldwid
denv
infect
manifest
clinic
dengu
fever
sever
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
increas
spread
dengu
viru
mosquito
vector
mani
subtrop
region
past
sever
decad
especi
latin
america
asia
highlight
need
addit
method
dengu
viru
surveil
diagnos
dengu
reli
detect
viral
nucleic
acid
antigen
blood
confirm
presenc
antidenv
igm
igg
antibodi
therefor
tradit
depend
rtpcr
elisa
viral
cell
cultur
method
dengu
diagnost
crucial
import
due
broad
spectrum
clinic
present
global
emerg
spread
uniqu
diseas
epidemiolog
possibl
clinic
relat
asyet
unknown
tropic
febril
pathogen
tradit
viral
detect
method
serolog
viru
isol
pcr
optim
detect
known
agent
howev
novel
highli
diverg
virus
easili
detect
approach
reli
priori
sequenc
antigen
cell
tropism
knowledg
pcrbase
assay
employ
degener
primer
may
success
target
conserv
region
within
relat
viru
group
unlik
bacteria
virus
lack
univers
conserv
genet
region
ribosom
rna
exploit
amplifi
virus
metagenom
analysi
enabl
system
detect
known
novel
viral
pathogen
approach
varieti
microarray
sequenc
strategi
virochip
panvir
microarray
platform
previous
util
detect
discoveri
virus
human
anim
sampl
deep
sequenc
shotgun
sequenc
human
clinic
sampl
use
viral
detect
novel
viru
discoveri
diverg
viru
genom
recoveri
viral
metagenom
approach
also
employ
diagnost
supplement
pathogen
detect
part
public
health
monitor
system
limit
shotgun
sequenc
viralenrich
librari
yet
util
deep
sequenc
data
current
avail
sequenc
platform
gener
million
billion
sequenc
read
per
run
far
exceed
largescal
shotgun
sequenc
deep
sequenc
clinic
sampl
hundr
thousand
million
sequenc
read
gener
per
sampl
incorpor
stepwis
viru
detect
pipelin
databas
search
use
basic
local
align
search
tool
blast
align
tool
use
identifi
sequenc
sampl
correspond
known
novel
virus
includ
present
low
concentr
deriv
virus
may
diverg
detect
pcr
microarray
method
deep
sequenc
repres
unbias
highli
sensit
method
identifi
viral
nucleic
acid
clinic
sampl
studi
describ
use
virochip
microarray
deep
sequenc
direct
viral
diagnosi
serum
case
acut
pediatr
febril
ill
tropic
urban
set
patient
clinic
data
serum
sampl
collect
part
ongo
pediatr
dengu
studi
managua
nicaragua
virochip
deep
sequenc
perform
posit
control
sampl
dengu
virusneg
serum
sampl
use
method
virus
detect
previous
neg
sampl
sequenc
deriv
known
appar
diverg
virus
virus
identifi
case
known
induc
symptom
consist
observ
though
definit
caus
agent
infect
remain
determin
acut
serum
sampl
collect
suspect
dengu
case
hospit
infantil
manuel
de
rivera
himjr
nation
pediatr
refer
hospit
managua
nicaragua
undergo
inform
consent
inform
consent
procedur
patient
enrol
studi
present
fever
histori
fever
less
day
one
follow
sign
symptom
headach
arthralgia
myalgia
retroorbit
pain
posit
tourniquet
test
petechia
sign
bleed
patient
defin
diagnosi
dengu
eg
pneumonia
exclud
suspect
dengu
case
test
dengu
viru
denv
infect
centro
nacion
de
referencia
cndr
nicaraguan
ministri
health
consid
laboratoryconfirm
denv
isol
denv
rna
detect
revers
transcriptasepolymeras
chain
reaction
rtpcr
seroconvers
observ
igm
captur
enzymelink
immunosorb
assay
elisa
pair
acut
convalesc
sera
increas
denvspecif
antibodi
demonstr
inhibit
elisa
pair
acut
convalesc
sera
patient
age
month
year
present
august
januari
approxim
one
half
suspect
dengu
case
test
neg
four
dengu
diagnost
assay
includ
metagenom
analysi
describ
case
pool
see
correspond
subset
patient
present
within
day
symptom
onset
report
fever
histori
fever
rash
sampl
pool
select
randomli
among
remain
sampl
posit
control
seven
sampl
pool
clinic
diagnos
viru
posit
includ
studi
protocol
review
approv
institut
review
board
irb
univers
california
berkeley
nicaraguan
ministri
health
total
nucleic
acid
ml
serum
extract
use
qiaamp
viral
rna
isol
kit
qiagen
copurifi
rna
dna
endtag
dsdna
librari
creat
essenti
previous
describ
rna
revers
transcrib
reaction
contain
reaction
buffer
mm
dithiothreitol
mm
dntp
pmole
primer
tct
tcc
gat
ctn
nnn
u
superscript
iii
invitrogen
ng
templat
follow
revers
transcript
sequenas
reaction
buffer
u
sequenas
dna
polymeras
affymetrix
ad
sampl
second
strand
synthesi
sequenas
reaction
perform
twice
start
dna
templat
would
convert
endtag
librari
molecul
result
librari
amplifi
pcr
use
primer
tct
tcc
gat
pcr
contain
reaction
buffer
mm
primer
mm
dntp
u
taq
dna
polymeras
ml
librari
templat
thermocycl
condit
min
cycl
sec
sec
minut
final
extens
minut
librari
process
microarray
hybrid
deep
sequenc
describ
microarray
hybrid
fraction
librari
amplifi
pcr
modifi
dntp
mixtur
includ
dutp
ambion
lieu
dttp
normal
mixtur
result
aminoallylcontain
dna
purifi
use
dna
clean
column
zymo
research
eluat
heat
dengu
viru
infect
global
health
concern
affect
mani
million
peopl
annual
worldwid
critic
first
step
proper
treatment
control
viru
infect
correct
diagnosi
tradit
diagnost
test
virus
depend
amplif
conserv
portion
viral
genom
detect
bind
antibodi
viral
protein
replic
viru
cell
cultur
method
major
shortcom
unabl
detect
diverg
novel
virus
priori
sequenc
serolog
cellular
tropism
inform
known
studi
use
two
approach
microarray
deep
sequenc
viru
identif
less
suscept
shortcom
use
unbias
tool
search
virus
blood
collect
nicaraguan
children
clinic
symptom
indic
dengu
viru
infect
current
dengu
viru
detect
assay
yield
neg
result
abl
identifi
known
diverg
virus
one
third
previous
neg
sampl
demonstr
util
approach
detect
virus
case
unknown
denguelik
ill
denatur
min
cool
briefli
ice
fluoresc
label
reaction
contain
mm
sodium
bicarbon
ph
dmso
mm
mono
nh
ester
ge
healthcar
hour
label
dna
purifi
use
column
ad
hybrid
reaction
contain
mm
hepe
ph
sd
hybrid
mixtur
heat
minut
appli
microarray
hybrid
overnight
follow
hybrid
array
wash
twice
ssc
sd
twice
scan
axon
genepix
microarray
scanner
three
analysi
tool
use
analyz
virochip
data
epredict
zscore
analysi
cluster
analysi
array
deem
posit
particular
viru
viru
identifi
least
two
method
virochip
result
deposit
ncbi
geo
databas
geo
access
seri
deep
sequenc
illumina
pairedend
adapt
sequenc
append
librari
molecul
use
pcr
essenti
previous
describ
librari
gener
primer
tabl
modifi
adapt
adapt
b
sequenc
illumina
sampl
revers
transcrib
librari
creat
amplifi
describ
virochip
librari
molecul
approxim
bp
purifi
nativ
polyacrylamid
gel
ethanol
precipit
pcr
amplifi
addit
cycl
use
primer
consist
illumina
adapt
primer
fulllength
illumina
adapt
b
primer
follow
condit
cycl
min
follow
cycl
min
amplicon
gener
correct
adapt
topolog
one
end
adapt
adapt
b
approxim
bp
separ
polyacrylamid
gel
electrophoresi
adapt
aa
adapt
bb
amplicon
migrat
differ
approxim
bp
smaller
larger
expect
size
addit
cycl
pcr
perform
use
fulllength
adapt
sequenc
primer
primer
librari
valid
sanger
sequenc
high
throughput
sequenc
follow
valid
sampl
combin
five
pool
sequenc
pool
one
four
revers
transcript
primer
includ
three
fournucleotid
barcod
sequenc
pool
five
barcod
locat
intern
adapt
sequenc
pool
sequenc
one
lane
flowcel
illumina
genom
analyz
ii
pool
hiseq
pool
pool
molecul
sequenc
nucleotid
pair
end
pool
molecul
nucleotid
pair
end
pairedend
sequenc
perform
sever
reason
doubl
overal
amount
data
gener
doubl
amount
sequenc
inform
per
molecul
provid
anchor
addit
sequenc
could
recov
subsequ
pcr
case
pcr
sanger
sequenc
use
confirm
virochip
deep
sequenc
call
recov
addit
sequenc
primer
sequenc
list
tabl
pcr
condit
minut
cycl
second
second
primer
depend
minut
minut
pcr
product
sizeselect
agaros
gel
purifi
purelink
gel
extract
kit
invitrogen
clone
sanger
sequenc
fulllength
polioviru
genom
rna
transcrib
mluilinear
plasmid
prib
xpa
use
rna
polymeras
previous
describ
polioviru
rna
mix
hela
total
rna
dilut
seri
rang
polioviru
grna
per
hela
rna
randomlyprim
dsdna
librari
prepar
hybrid
virochip
analyz
describ
predict
circoviruslik
replicas
sequenc
search
ncbi
nonredund
protein
databas
blastx
e
valu
align
sequenc
retriev
consolid
use
cdhit
set
repres
sequenc
cdhit
version
paramet
c
sequenc
align
geneiou
global
align
free
end
gap
trim
amino
acid
overlap
share
two
recov
sequenc
neighborjoin
tree
gener
geneiou
tree
builder
initi
fastq
data
pool
lane
bin
barcod
barcodesplit
read
trim
nontempl
deriv
potenti
errorpron
sequenc
randomli
incorpor
nucleotid
n
barcod
base
sequenc
correspond
random
hexam
leav
pool
pool
pool
base
per
read
lowest
complex
fraction
identifi
sequenc
lzw
ratio
compress
sizeuncompress
size
less
read
align
human
genom
build
first
use
blat
fastmap
flag
filter
remain
read
align
use
blat
without
flag
pair
read
least
one
read
pair
least
ident
databas
mark
human
remov
subsequ
analys
remov
read
identifi
human
blat
remain
read
align
filter
map
human
transcriptom
use
nucleotid
blast
blastn
version
word
size
e
valu
remain
read
next
align
human
genom
use
blastn
word
size
e
valu
filter
align
human
genom
blastn
word
size
e
valu
human
filter
reanalyz
distribut
complex
read
observ
rel
enrich
read
lzw
ratio
lower
differ
lzw
ratio
distribut
inher
properti
differ
read
length
read
remov
analysi
look
read
viral
homolog
search
nonredund
nucleotid
databas
nt
use
blastn
word
size
e
valu
read
map
nt
align
nonredund
protein
databas
nr
use
translat
blast
blastx
word
size
e
valu
order
make
specif
virusposit
call
implement
set
rule
minim
fals
posit
maintain
sensit
order
reduc
number
fals
posit
sequenc
may
share
ident
equal
viral
nonvir
genom
restrict
analysi
queri
whose
best
align
anim
viral
sequenc
number
dataset
detect
human
klasseviru
viru
identifi
studi
lab
human
polioviru
use
virochip
sensit
experi
sequenc
mosquito
densovirus
also
studi
lab
well
moloney
murin
leukemia
viru
mmlv
polymeras
use
sequenc
librari
prepar
believ
read
repres
lab
contamin
other
studi
prepar
sequenc
librari
locat
report
similar
find
account
contamin
posit
call
made
virus
support
read
read
known
contamin
final
order
avoid
make
call
base
potenti
spuriou
align
consid
virus
least
read
support
presenc
initi
screen
serum
sampl
virochip
pan
viral
detect
microarray
done
complement
deep
sequenc
analysi
order
compar
sensit
two
approach
includ
blind
posit
control
sampl
previous
diagnos
clinic
posit
n
n
hepat
viru
hav
n
virochip
success
identifi
correct
viru
posit
control
case
dengu
viru
posit
sampl
correct
serotyp
well
tabl
also
identifi
ten
sampl
posit
torqu
teno
viru
ttv
appli
vitro
transcrib
polioviru
rna
dilut
hela
cell
total
rna
virochip
addit
posit
control
quantifi
virochip
sensit
use
epredict
analysi
tool
lowest
detect
concentr
polioviru
viral
rna
per
hela
rna
molecul
approxim
polio
grna
per
cell
equival
hela
rna
figur
raw
read
first
separ
barcod
analyz
individu
data
set
describ
method
bioinformat
filter
process
consist
remov
low
complex
low
qualiti
sequenc
filter
sequenc
human
origin
figur
filter
step
averag
initi
read
remain
absolut
averag
read
remain
per
sampl
figur
tabl
barcod
dataset
appear
larger
nonhuman
fraction
upon
inspect
nonhuman
compon
account
known
librari
prepar
contamin
e
coli
cerevisia
read
remain
filter
compar
sequenc
ncbi
nonredund
nucleotid
protein
databas
use
blastn
blastx
respect
virusderiv
sequenc
detect
posit
control
sampl
previous
neg
serum
sampl
tabl
sampl
unabl
identifi
viru
sequenc
detect
criteria
method
recov
viru
sequenc
match
expect
viral
genom
posit
control
sampl
fraction
viral
sequenc
control
span
order
magnitud
total
read
two
hav
posit
control
sampl
aliquot
serum
sampl
process
analyz
independ
fraction
viral
read
duplic
within
demonstr
librari
prepar
sequenc
bioinformat
pipelin
capabl
reproduc
detect
evid
clinic
relev
infect
addit
control
two
noncontrol
sampl
contain
evid
rna
viru
sequenc
sampl
read
deriv
gb
viru
c
gbvc
also
known
hepat
g
viru
essenti
ident
gbvc
databas
sequenc
detect
sequenc
best
align
dsrna
virus
retrovirus
except
human
endogen
retroviru
contamin
mlv
rtderiv
sequenc
see
method
human
herpesviru
sequenc
detect
previous
neg
sampl
posit
sampl
averag
normal
read
count
read
per
sampl
rang
repres
dataset
tabl
read
possess
high
sequenc
ident
refer
genom
sequenc
gi
gener
align
refer
genom
investig
depth
genom
posit
sequenc
coverag
across
genom
figur
although
read
constitut
rel
small
fraction
dataset
coverag
across
entir
genom
mani
gene
posit
sampl
addit
detect
human
herpesviru
also
known
epstein
barr
viru
sequenc
one
sampl
sequenc
virtual
ident
previous
report
sequenc
one
sampl
also
contain
read
similar
anoth
dsdna
viru
african
swine
fever
viru
asfv
previous
detect
human
serum
case
read
best
match
asfv
capsid
sequenc
rel
diverg
amino
acid
ident
similar
nonasfv
sequenc
blastx
attempt
recov
addit
asfv
sequenc
pcr
unsuccess
also
identifi
sequenc
deriv
singlestrand
dna
virus
sampl
one
sampl
detect
parvoviru
read
high
ident
databas
sequenc
sequenc
relat
variou
member
anellovirida
viru
famili
ttv
detect
sampl
frequenc
detect
within
rang
report
previous
human
serum
ttv
sequenc
rang
amino
acid
ident
closest
databas
match
pursu
sequenc
ttv
known
form
diverg
famili
virus
commonli
detect
appar
healthi
individu
sequenc
similar
member
circovirida
famili
ssdna
virus
detect
sampl
sequenc
align
circoviru
circoviruslik
replicas
protein
sequenc
align
rang
amino
acid
ident
appear
deriv
replicas
gene
multipl
relat
speci
tabl
circoviruslik
replicas
sequenc
detect
human
stool
anim
environment
sampl
detect
rang
circoviruslik
read
per
posit
sampl
tabl
low
sequenc
coverag
prohibit
complet
genom
sequenc
assembl
inform
sequencespecif
primer
design
often
abl
recov
larger
continu
region
replicas
gene
pcr
sanger
sequenc
genbank
access
see
tabl
term
extend
replicaselik
sequenc
circoviruslik
cvlni
compar
repres
set
replicas
sequenc
figur
sequenc
close
relat
circoviruslik
viru
rwe
gi
circular
singlestrand
dna
viru
previous
found
reclaim
water
sampl
florida
sequenc
close
relat
replicas
sequenc
recov
sequenc
overlap
sequenc
enough
includ
phylogenet
analysi
similar
circoviruslik
cba
circoviruslik
genom
identifi
chesapeak
bay
environment
sampl
gi
subset
posit
sampl
tabl
contain
sequenc
one
viru
may
evid
coinfect
almost
case
multipl
virus
involv
ttvderiv
sequenc
along
circoviruslik
sequenc
sampl
two
sampl
contain
circoviruslik
sequenc
asfvlik
sampl
gbvc
sequenc
sampl
studi
examin
viru
divers
serum
sampl
nicaraguan
children
unknown
acut
febril
ill
perform
virochip
microarray
deep
sequenc
analys
posit
control
undiagnos
sampl
method
succeed
detect
expect
viru
posit
control
sampl
virochip
analysi
produc
put
viral
hit
previous
neg
sampl
wherea
deep
sequenc
reveal
viru
viruslik
sequenc
studi
demonstr
util
metagenom
strategi
detect
viru
sequenc
multipl
human
serum
sampl
first
util
secondgener
sequenc
simultan
investig
mani
case
acut
unknown
tropic
ill
monitor
emerg
spread
novel
human
pathogen
tropic
region
central
public
health
concern
metagenom
analysi
enabl
system
viral
detect
known
novel
viral
pathogen
employ
diagnost
supplement
pathogen
detect
part
public
health
monitor
system
epidemiolog
survey
despit
headway
metagenom
viru
detect
studi
confront
sever
remain
difficulti
concern
diagnost
accuraci
foremost
concern
includ
enhanc
sensit
specif
deep
sequencingbas
diagnost
method
reevalu
evid
diseas
causal
light
increasingli
sensit
nucleic
acid
detect
pathogen
discoveri
method
former
requir
improv
strategi
biochem
enrich
comput
identifi
viral
sequenc
reduc
host
background
sequenc
latter
requir
cautiou
reconsider
criteria
use
establish
causal
link
microb
diseas
well
extens
casebycas
followup
studi
employ
classic
laboratori
method
serolog
analysi
cell
cultur
amplif
import
highlight
observ
viral
sequenc
sequenc
data
insuffici
establish
role
viru
diseas
causal
like
detect
strategi
deep
sequenc
serv
inform
secondari
test
includ
seroconvers
assay
nucleic
acid
test
cell
cultur
amplif
addit
investig
plausibl
diseas
mechan
detect
viru
sequenc
concentr
low
read
viru
sequenc
detect
clinic
sampl
vanishingli
low
copi
number
may
reflect
sever
possibl
hostmicrob
scenario
sequenc
detect
may
pathogen
viru
capabl
caus
ill
low
copi
number
indirect
effect
ubiquit
nondiseas
caus
microb
viru
outsid
primari
replic
site
lowlevel
contamin
artifact
sampl
collect
timingprocess
remain
incomplet
immun
clearanc
addit
evid
must
consid
case
defin
hostmicrob
relationship
studi
compar
perform
virochip
deep
sequenc
detect
viru
sequenc
human
serum
limit
detect
virochip
approxim
one
part
polioviru
control
microarray
probe
perfect
sequenc
complementar
figur
sensit
deep
sequenc
limit
number
read
gener
per
sampl
read
depth
studi
detect
viru
sequenc
two
part
per
million
nearli
everi
viru
detect
microarray
also
detect
deep
sequenc
addit
numer
sampl
n
sequenc
reveal
virus
detect
virochip
tabl
two
instanc
virochip
analysi
identifi
viru
ttv
detect
deep
sequenc
tabl
deep
sequenc
therefor
superior
method
novel
viru
discoveri
sensit
provid
conclus
genotyp
inform
virochip
ncbi
taxid
name
viru
speci
highest
number
hit
among
virus
blast
hit
given
two
sampl
prepar
aliquot
serum
sampl
c
deep
sequenc
dataset
sampl
read
match
ttv
posit
identif
threshold
virochip
rel
fast
inexpens
method
best
appli
sampl
expect
viru
copi
number
present
level
greater
host
sequenc
unabl
detect
viru
two
third
denguelik
ill
sampl
result
could
reflect
true
neg
statu
would
result
nonvir
infect
ill
due
noninfecti
agent
complet
immunolog
clearanc
altern
neg
result
could
reflect
failur
diagnost
approach
due
imperfect
sensit
unsatisfactori
sampl
prepar
improp
sampl
type
failur
recogn
highli
diverg
viral
sequenc
presenc
sequenc
lack
even
remot
similar
known
speci
also
highlight
need
develop
de
novo
assembl
method
metagenom
data
assembl
data
increas
depth
enhanc
sequenc
comparison
method
enabl
sensit
detect
diverg
virus
metagenom
sampl
determin
etiolog
human
diseas
symptom
overlap
denguelik
ill
import
understand
full
spectrum
emerg
previous
uncharacter
pathogen
tropic
popul
studi
acut
serum
sampl
neg
dengu
viru
case
pediatr
denguelik
ill
posit
primari
infect
caus
undifferenti
febril
ill
exanthem
subitum
roseola
infantum
sixth
diseas
acut
ill
high
fever
rash
typic
resolv
three
seven
day
exanthem
subitum
common
diseas
infant
worldwid
infect
frequent
occur
month
age
seroposit
estim
adult
popul
develop
countri
posit
patient
studi
month
old
present
fever
rash
tabl
detect
multipl
kilobas
sequenc
posit
sampl
sequenc
deriv
multipl
viral
genom
region
figur
acut
infect
latent
persist
host
quiescent
product
infecti
virion
low
level
viral
replic
latenc
believ
endur
sever
cell
type
includ
monocyt
bone
marrow
progenitor
cell
may
undergo
chromosom
integr
vertic
transmit
confound
effect
chromosom
integr
make
differenti
activ
latent
infect
difficult
detect
sequenc
sequenc
virus
tropic
denguelik
ill
wwwplosntdsorg
serum
dna
previou
studi
detect
integr
genom
sequenc
healthi
blood
sampl
sinc
detect
nucleic
acid
serum
alon
prove
activ
viral
infect
definit
confirm
sequenc
sampl
deriv
vertic
transmiss
chromosom
integr
viru
howev
clinic
epidemiolog
viru
sequenc
data
suggest
may
etiolog
agent
febril
ill
case
primari
infect
major
caus
infant
hospit
unit
state
clinic
burden
like
share
throughout
tropic
world
given
similar
seropreval
rate
result
studi
illustr
import
administ
diagnost
test
case
suspect
denguelik
ill
infant
dengueendem
region
differenti
case
exanthem
subitum
ubiquit
selflimit
childhood
ill
dengu
fever
carri
greater
risk
sever
clinic
complic
death
similarli
one
sampl
posit
parvoviru
sequenc
may
case
acut
infect
commonli
acquir
childhood
viru
parvoviru
manifest
erythema
infectiosum
fifth
diseas
condit
associ
characterist
slap
cheek
rash
infect
also
subclin
result
mild
nonspecif
symptom
possibl
parvoviru
infect
caus
symptom
case
tabl
though
identif
viral
sequenc
definit
demonstr
causal
histogram
genom
coverag
gener
align
read
minimum
ident
total
read
length
genom
depth
sequenc
coverag
calcul
total
kb
align
sequenc
per
kb
bin
refer
genom
genom
track
represent
adapt
dominguez
et
al
blue
box
repres
conserv
gene
across
betaherpesviru
subfamili
orang
box
repres
core
gene
across
herpesviru
famili
green
box
repres
late
structur
gene
asterisk
denot
origin
lytic
gene
replic
inset
text
histogram
sampl
code
coverag
shown
sampl
greater
read
sequenc
virus
tropic
denguelik
ill
wwwplosntdsorg
epstein
barr
viru
sequenc
found
serum
one
patient
present
rel
sever
symptom
die
hospit
tabl
infect
nearli
univers
occurr
first
two
decad
life
primari
infect
adolesc
adult
manifest
infecti
mononucleosi
chronic
infect
associ
variou
malign
later
life
primari
infect
childhood
howev
usual
asymptomat
produc
mild
symptom
clear
infect
alon
caus
ill
case
addit
virus
plausibl
diseas
associ
exist
mani
sampl
contain
sequenc
virus
wellestablish
link
human
diseas
includ
two
sampl
posit
gbvc
contain
asfvlik
ttvlike
circoviruslik
sequenc
circovirida
famili
extraordinarili
divers
group
small
singlestrand
circular
dna
virus
includ
cyclovirus
genu
cycloviru
circovirus
genu
circoviru
commonli
detect
human
stool
blood
also
environment
sampl
circoviru
speci
beak
feather
diseas
viru
porcin
circoviru
associ
diseas
bird
pig
host
respect
pathogen
potenti
circovirus
human
remain
unconfirm
circoviruslik
sequenc
report
detect
nucleic
acid
librari
prepar
acut
human
serum
close
relat
circoviruslik
virus
figur
first
report
environment
sampl
bat
unsuccess
recov
full
genom
sequenc
correspond
circoviruslik
sequenc
yet
possibl
prove
sequenc
environment
artifact
introduc
sampl
prepar
also
possibl
sequenc
deriv
organ
giardia
intestinali
entamoeba
dispar
whose
genom
encod
protein
share
amino
acid
similar
circoviru
replicas
protein
figur
furthermor
yet
establish
whether
circovirus
capabl
replic
human
pend
addit
screen
serolog
studi
detect
circoviruslik
sequenc
human
serum
interpret
caution
metagenom
approach
provid
effect
highthroughput
method
detect
uncharacter
viru
divers
tropic
set
mani
sampl
simultan
find
present
studi
knowledg
wellcharacter
previous
unknown
virus
present
serum
collect
pediatr
denguelik
ill
patient
advanc
understand
applic
metagenom
approach
human
pathogen
detect
deep
sequenc
analysi
clinic
sampl
hold
tremend
promis
diagnost
tool
permit
detect
mani
differ
virus
simultan
includ
present
lowcopi
number
diverg
origin
major
remain
barrier
highthroughput
sequenc
strategi
becom
standard
diagnost
practic
includ
prohibit
cost
lengthi
sampl
prepar
time
comput
intens
data
analysi
requir
challeng
magnifi
resourcelimit
set
nicaragua
gradual
address
industri
hardwar
technic
advanc
steadili
decreas
perbas
cost
deep
sequenc
result
present
strengthen
expect
multiplex
sampl
prepar
bioinformat
data
filter
within
framework
current
secondgener
sequenc
platform
longterm
bidirect
partnership
develop
countri
collabor
facilit
easier
access
techniqu
current
avail
onsit
deep
sequenc
also
import
provid
train
opportun
local
scientist
develop
relev
pathogen
test
diagnost
polici
studi
expand
understand
viru
divers
pediatr
denguelik
ill
nicaragua
applic
genom
detect
techniqu
tropic
set
find
particularli
valuabl
given
press
need
improv
global
emerg
pathogen
surveil
figur
virochip
sensit
use
polioviru
control
rna
virochip
detect
one
polioviru
grna
background
hela
rna
molecul
polioviru
rna
mix
hela
total
rna
analyz
virochip
eighti
enteroviru
virochip
oligo
found
respons
polioviru
rna
mean
fold
background
normal
intens
oligo
plot
background
defin
normal
intens
oligo
helaonli
control
sampl
top
epredict
hit
sampl
human
enteroviru
c
pdf
figur
pdf
